X-linked Wiskott-Aldrich syndrome in a girl

New England Journal of Medicine

Volumn 338, Issue 5, 1998, Pages 291-295

  Parolini, Ornella ^a   Ressmann, Gabriele ^b   Haas, Oskar A ^b   Pawlowsky, Johanna ^b   Gadner, Helmut ^b   Knapp, Walter ^a   Holter, Wolfgang ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; FEMALE; HUMAN; INFANT; LYMPHOCYTE; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMATITIS; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME; X CHROMOSOME; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKED DISORDER;

CHILD; DOSAGE COMPENSATION, GENETIC; FEMALE; GENES, RECESSIVE; HUMANS; LINKAGE (GENETICS); MUTATION; PROTEINS; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN; X CHROMOSOME;

EID: 0032576743     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199801293380504     Document Type: Article

References (26)

1. Remold-O'Donnell E, Rosen FS, Kenney DM. Defects in Wiskott-Aldrich syndrome blood cells. Blood 1996;87:2621-31.
2. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994;78:635-44. [Erratum, Cell 1994;79: 922a.]
3. Kwan SP, Hagemann TL, Radtke BE, Blaese RM, Rosen FS. Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proc Natl Acad Sci USA 1995;92:4706-10.
4. Schwarz K. WASPbase: a database of WAS-and XLT-causing mutations. Immunol Today 1996;17:496-502.
5. Stewart DM, Treiber-Held S, Kurman CC, Facchetti F, Notarangelo LD, Nelson DL. Studies of the expression of the Wiskott-Aldrich syndrome protein. J Clin Invest 1996;97:2627-34.
6. Parolini O, Berardelli S, Riedl E, et al. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. Blood 1997;90:70-5.
7. Smith CIE, Notarangelo LD. Molecular basis for X-linked immunodeficiencies. Adv Genet 1997;35:57-115.
8. Fearon ER, Kohn DB, Winkelstein JA, Vogelstein B, Blaese RM. Carrier detection in the Wiskott Aldrich syndrome. Blood 1988;72:1735-9.
9. Greer WL, Kwong PC, Peacocke M, Ip P, Rubin LA, Siminovitch KA. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. Genomics 1989;4:60-7.
10. Wengler G, Gorlin JB, Williamson JM, Rosen FS, Bing DH. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 1995;85:2471-7.
11. Conley ME, Wang WC, Parolini O, Schapiro DN, Campana D, Siminovitch KA. Atypical Wiskott-Aldrich syndrome in a girl. Blood 1992;80: 1264-9.
12. Russell SJ, Nisen PD. Random X chromosome inactivation in a female with a variant of Wiskott-Aldrich syndrome. Br J Haematol 1995;90:210-2.
13. Kondoh T, Hayashi K, Matsumoto T, et al. Two sisters with clinical diagnosis of Wiskott-Aldrich syndrome: is the condition in the family autosomal recessive? Am J Med Genet 1995;60:364-9.
14. Wengler GS, Parolini O, Fiorini M, et al. A PCR-based non-radioactive X-chromosome inactivation assay for genetic counseling in X-linked primary immunodeficiencies. Life Sci 1997;61:1405-11.
15. Wengler GS, Notarangelo LD, Berardelli S, et al. High prevalence of nonsense, frame-shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood 1995;86:3648-54.
16. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992;51:1229-39.
17. Kolluri R, Shehabeldin A, Peacocke M, et al. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum Mol Genet 1995;4:1119-26.
18. Lyon MF. Mechanisms and evolutionary origins of variable X-chromosome activity in mammals. Proc R Soc Lond B Biol Sci 1974;187:243-68.
19. Clarke JT, Greer WL, Strasberg PM, Pearce RD, Skomorowski MA, Ray PN. Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl. Am J Hum Genet 1991;49:289-97.
20. Nisen PD, Waher PG. Nonrandom X chromosome DNA methylation patterns in hemophiliac females. J Clin Invest 1989;83:1400-3.
21. Azofeifa J, Voit T, Hubner C, Cremer M. X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes. Hum Genet 1995;96:167-76.
22. Aral B, de Saint Basile G, Al-Garawi S, Kamoun P, Ceballos Picot I. Novel nonsense mutation in the hypoxanthine guanine phosphoribosyl-transferase gene and nonrandom X-inactivation causing Lesch-Nyhan syndrome in a female patient. Hum Mutat 1996;7:52-8.
23. Belmont JW. Genetic control of X inactivation and processes leading to X-inactivation skewing. Am J Hum Genet 1996;58:1101-8.
24. Lee JT, Jaenisch R. The (epi)genetic control of mammalian X-chromosome inactivation. Curr Opin Genet Dev 1997;7:274-80.
25. Naumova AK, Plenge RM, Bird LM, et al. Heritability of X chromosome-inactivation phenotype in a large family. Am J Hum Genet 1996;58: 1111-9.
26. Plenge RM, Hendrich BD, Willard HF. A mutation in the XIST promoter in a family with non-random X chromosome inactivation. Am J Hum Genet 1995;57:A30. abstract.